Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-08

Clinical Trial Update: Psilocybin for Treatment of OCD-2 [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates a Phase 1/Phase 2 study evaluating psilocybin for treatment of obsessive-compulsive disorder, sponsored by Francisco A Moreno,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Francisco A Moreno | Conditions: Obsessive - Compulsive Disorder | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING